This report contains market size and forecasts of Biologicals for Systemic Lupus Erythematosus in Global, including the following market information:
Global Biologicals for Systemic Lupus Erythematosus Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biologicals for Systemic Lupus Erythematosus market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rituximab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biologicals for Systemic Lupus Erythematosus include Roche, GlaxoSmithKline, Shanghai Junshi Biosciences and ACEA Biosciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologicals for Systemic Lupus Erythematosus companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologicals for Systemic Lupus Erythematosus Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biologicals for Systemic Lupus Erythematosus Market Segment Percentages, by Type, 2021 (%)
Rituximab
Belimumab
Anifrolumab
UBP-1213
Other
Global Biologicals for Systemic Lupus Erythematosus Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biologicals for Systemic Lupus Erythematosus Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Pharmacy
Other
Global Biologicals for Systemic Lupus Erythematosus Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biologicals for Systemic Lupus Erythematosus Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologicals for Systemic Lupus Erythematosus revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biologicals for Systemic Lupus Erythematosus revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
GlaxoSmithKline
Shanghai Junshi Biosciences
ACEA Biosciences